WebIGM-8444 is an engineered, multivalent agonistic IgM antibody with 10 binding sites to DR5 that induces cancer cell apoptosis through efficient DR5 multimerization. IGM-8444 bound to ... IGM Biosciences Inc., Mountain View, California. Note: Supplementary data for this article are available at Molecular Cancer WebJul 8, 2024 · Dan Chen IGM IGM Biosciences is still shying away from the limelight, only divulging in a three-paragraph statement that its lead program, a CD20xCD3 bispecific, is expected to...
Daniel Chen, MD, PhD, Chief Medical Officer, IGM Biosciences
WebAphase 1 dose‐escalation study of IGM‐2323, a novel anti‐CD20 x anti‐CD3 IgM T‐cell engager in patients with advanced B‐cell malignancies Elizabeth Budde, 1MD 3PhD , Ajay K. 4Gopal, MD2, Won 5SeogKim, MD PhD , Ian Flinn, MD PhD , Chan Y. Cheah, MBBS , Loretta Nastoupil, MD6, Matthew 7Matasar, 11MD , Catherine Diefenbach, MD8, … WebSep 17, 2024 · IGM Biosciences, Inc. ClinicalTrials.gov Identifier: NCT04553692 Other Study ID Numbers: IGM-8444-001 : First Posted: September 17, 2024 Key Record Dates: Last Update Posted: January 9, 2024 Last Verified: January 2024 Layout table for additional information; Studies a U.S. FDA-regulated Drug Product: ... geoffrey street blood clinic
IGM Biosciences Announces the Appointment of Chris H. Takimoto…
WebMar 29, 2024 · Pat Greenhouse/The Boston Globe via Getty. Paris-based Sanofi and Mountain View, California-based IGM Biosciences inked a collaboration deal for oncology, immunology and inflammation that could surpass $6 billion. The two companies will partner on immunoglobulin M (IgM) antibody agonists against three cancer targets and three … WebEducation. College; University of Georgia. Athens, GA. Medical School; Mercer University School of Medicine. Macon, GA. Residency; Mercer University School of Medicine at … WebDan Chen, MD, Ph.D, is Chief Medical Officer at IGM Biosciences, focused on the development of novel engineered therapeutics. Prior to IGM, he was Vice President, … chris miles musician